Livzon Pharmaceutical Group Inc.
Livzon Pharmaceutical Group Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Prospective Trial Evaluating the Efficacy and Tumor Immune Microenvironment Remodeling Induced by SFI Plus PD-1 Inhibitors and PBC in Resectable NSCLC | Resectable Locally Advanced Non-Squamous NSCLC; Tear Disorder | Not yet recruiting | Phase 4 | 2026-09-28 | NCT07843251 | |
| Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty | Circulatory Disease | Recruiting | Phase 2 | 2025-05-09 | NCT06963320 | |
| A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis | Digestive System Diseases, digestive system disorder, duodenal disorder, esophageal disorder, esophagitis, gastroenteritis, intestinal disorder, peptic esophagitis, peptic ulcer disease, stomach disorder | Recruiting | Phase 3 | 2025-02-27 | NCT06850480 |